ETR/RHO (ETR/RHO)

Deutsche Börse Xetra: ETR/RHO · EUR

€438

-1.20 (-0.3%)· Recorded snapshot

Market cap	344.1B
Revenue (ttm)	68.2B
Net income (ttm)	13.4B
EPS (ttm)	€16.6
P/E (trailing)	26.4x
P/E (forward)	18.7x
Dividend	€11.9 (2.72%)
Volume	463

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 68.2B
Net income (ttm): 13.4B
EPS (ttm): €16.6
P/E (trailing): 26.4x
P/E (forward): 18.7x
Market cap: 344.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E26.4

P25 n/aP50 n/aP75 n/a

ROE38.1

P25 n/aP50 n/aP75 n/a

ROIC28.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/RHO indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

CHF

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	DE
Earnings date	2026-10-28
Employees	103,249
Employees change	-356
Employees growth	-0.34%
Enterprise value	EUR 374B
Exchange	Deutsche Börse Xetra
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1896
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CH0012032113
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Market cap	EUR 344.1B
Next earnings date	2026-10-28
Price	EUR 438.00
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	etr/RHO
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	20.44x
Average P/E ratio (3Y)	20.61x
Average P/E ratio (5Y)	20.31x
Earnings yield	3.79%
EV/Earnings	28.04x
EV/EBIT	16.63x
EV/EBITDA	14.3x
EV/FCF	21.98x
EV/Sales	5.5x
FCF / EV yield	4.55%
FCF yield	4.94%
Forward P/E	18.68x
Graham number	139.2306
Graham upside	-68.3%
Lynch fair value	EUR 85.09
Lynch upside	-80.63%
P/(FCF - SBC) ratio	21.4x
P/(OCF - SBC) ratio	17.2x
P/B ratio	8.67x
P/E ratio	26.38x
P/FCF ratio	20.22x
P/OCF ratio	16.43x
P/S ratio	5.06x
Price / tangible book value	56.84x
Price/EBITDA ratio	13.29x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.12%
EBITDA margin	38.06%
Effective tax rate	18.74%
FCF margin	25.02%
Gross margin	74.17%
Operating margin	33.12%
Pretax margin	25.98%
Profit margin	19.6%
Profit per employee	EUR 129,482
Profitable quarters	47
Profitable years	23
Revenue per employee	EUR 660,568
ROA	13.51%
ROA (5Y)	13.31%
ROCE	30.06%
ROE	38.11%
ROE (5Y)	38.06%
ROIC	28.1%
ROIC (5Y)	32.56%
SBC / revenue	1.38%
Tax / revenue	4.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	30.57%
EPS growth (Q)	-7.69%
EPS growth (QoQ)	25.11%
EPS growth 10Y	3.82%
EPS growth 3Y	3.87%
EPS growth 5Y	-1.14%
EPS growth years	1
FCF growth	-0.29%
FCF growth (Q)	11.9%
FCF growth (QoQ)	-37.37%
FCF growth 3Y	6.53%
FCF growth 5Y	-0.37%
Gross profit growth	-1.65%
Gross profit growth (Q)	-2.07%
Gross profit growth 3Y	0.36%
Gross profit growth 5Y	0.78%
Net income growth	30.88%
Net income growth (Q)	-7.27%
Net income growth (QoQ)	25.61%
Net income growth 3Y	3.82%
Net income growth 5Y	-2.52%
Net income growth years	1
OCF growth	0.56%
OCF growth (Q)	7.54%
OCF growth (QoQ)	-35.03%
OCF growth 10Y	3.05%
OCF growth 3Y	5.46%
OCF growth 5Y	-0.34%
Operating income growth	2.89%
Operating income growth (Q)	-0.94%
Operating income growth 3Y	3.16%
Operating income growth 5Y	1.78%
Revenue growth	-0.83%
Revenue growth (Q)	-1.25%
Revenue growth (QoQ)	-0.17%
Revenue growth 10Y	2.01%
Revenue growth 3Y	0.23%
Revenue growth 5Y	0.28%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.9B
Depreciation and amortization	EUR 3.4B
EBIT	EUR 22.6B
EBITDA	EUR 26B
EPS	EUR 16.61
Financing cash flow	EUR -14.5B
Free cash flow	EUR 17.1B
Free cash flow minus SBC	EUR 16.1B
Gross profit	EUR 50.6B
Income taxes	EUR 3.3B
Investing cash flow	EUR -8.6B
Net borrowing	EUR -2.1B
Net cash flow	EUR -2.3B
Net income	EUR 13.4B
Operating cash flow minus SBC	EUR 20.1B
Operating income	EUR 22.6B
Revenue	EUR 68.2B
Stock-based compensation	EUR 938.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	EUR 44.45
Debt / EBITDA	1.37
Debt / equity	0.91
Debt / FCF	2.11
Goodwill	EUR 8.4B
Interest coverage	18.24
Long-term assets	EUR 68B
Long-term liabilities	EUR 35.4B
Net cash (debt)	EUR -25.5B
Net cash / market cap	-7.4%
Net debt / EBITDA	0.98
Net debt / equity	0.64
Net debt / FCF	1.5
Piotroski F-Score	5
Property, plant and equipment	EUR 25.4B
Shareholders' equity	EUR 39.8B
Tangible book value	EUR 6.1B
Tangible book value per share	EUR 7.62
Total assets	EUR 106.4B
Total cash	EUR 10.5B
Total debt	EUR 36.1B
Total liabilities	EUR 66.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	EUR 38.4B
Current liabilities	EUR 31.2B
Current ratio	1.23
Inventory turnover	2.07
Net working capital	EUR 3.7B
Quick ratio	0.8
Working capital	EUR 7.1B
Working capital turnover	9.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.31%
Dividend growth	17.12%
Dividend growth (10Y)	4.78%
Dividend growth (3Y)	7.43%
Dividend growth (5Y)	7.69%
Dividend growth years	4
Dividend payment date	2026-03-16
Dividend payment years	28
Dividend payout frequency	Annual
Dividend per share	EUR 11.93
Dividend yield	2.72%
Ex-dividend date	2026-03-12
Last dividend	EUR 11.93
Payout ratio	63.22%
Shareholder yield	2.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	104.33%
10Y return CAGR	10%
10Y total return	159.23%
150-day SMA	EUR 377.29
15Y price change	259.85%
15Y return CAGR	11.91%
15Y total return	440.48%
1D price change	-0.27%
1M price change	10.8%
1M total return	10.8%
1W price change	3.29%
1W total return	3.29%
1Y price change	46.11%
1Y return CAGR	50.92%
1Y total return	50.88%
20-day SMA	EUR 408.60
200-day SMA	EUR 379.67
20Y price change	188%
20Y return CAGR	8.4%
20Y total return	401.96%
3M price change	12.39%
3M total return	12.39%
50-day SMA	EUR 397.51
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 441.00
52-week high date	2026-10-28
52-week low	EUR 292.20
52-week low date	2025-11-03
6M price change	22.41%
6M total return	22.41%
All-time high	EUR 13,700.00
All-time high date	2000-11-22
All-time low	EUR 80.00
All-time low date	2001-11-07
Average true range (ATR)	EUR 7.57
Average volume	708.5
Change from 52-week high	-0.68%
Change from 52-week low	49.9%
Change from all-time high	-96.79%
Change from all-time low	449%
Change from open	-0.27%
Day's gap	0%
Dollar volume	EUR 202,794
High price	EUR 441.00
Low price	EUR 434.40
Monthly RSI	74.36
Open price	EUR 439.20
Position in 52-week range	54.55%
Previous close	EUR 439.20
Price vs 150-day SMA	16.41%
Price vs 20-day SMA	7.49%
Price vs 200-day SMA	15.68%
Price vs 50-day SMA	10.49%
Relative volume	0.65
RSI	74.06
Sharpe ratio	1.72
Sharpe ratio (3Y)	0.99
Sharpe ratio (5Y)	0.59
Sortino ratio	3.08
Sortino ratio (3Y)	2.37
Sortino ratio (5Y)	1.43
Volume	463
Weekly RSI	66.92
YTD price change	20.79%
YTD total return	24.74%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723.7M
Shares change (QoQ)	0.5%
Shares change (YoY)	0.31%
Shares held by insiders	9.17%
Shares held by institutions	28.86%

Deeper analysis on ETR/RHO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/RHO report

Is a complete ETR/RHO research report available?

No complete published report is available for etr/RHO (ETR/RHO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/RHO (ETR/RHO)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/RHO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/RHO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/RHO

Frequently asked questions